Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BWAY · NASDAQ · Surgical & Medical Instruments & Apparatus · Foreign private issuer
Brainsway (BWAY) · oqro.io/stocks/BWAY · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$8.98−0.13 (−1.43%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
No open-market purchase by an insider of Brainsway is on record in SEC filings since 2006.
No open-market sale by an insider of Brainsway (BWAY) was filed with the SEC in the last 90 days.
No trade in Brainsway (BWAY) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+21.5% (+$1.59) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $7.39 on Nov 18, 2025 to $8.98 on Nov 18, 2026 (+21.5%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 6 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Surgical & Medical Instruments & Apparatus company based in Jerusalem, Israel. Foreign private issuer: reports on Form 20-F or 40-F.
Surgical & Medical Instruments & Apparatus company based in Jerusalem, Israel. Foreign private issuer: reports on Form 20-F or 40-F. Its directors and officers file insider-trading forms (Form 4) only since 18 March 2026.
Last 12 months
+21.5%
Market value
–
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 199K shares sold short, −11.8% vs the previous count, 2.5 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
2 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 13, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
2 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 12, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Feb 13, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Against the S&P 500 over the year
Since Nov 14, 2025, BWAY is up 14.0% and the index fund is up 8.7%: 5 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much BWAY moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
People read Brainsway's Wikipedia article about 8 times a day over the last week, close to the 8 on a usual day of the three months before.
May 13, 2026Busiest day: 60 views on Sep 23, 2026Nov 18, 2026
Views of the article Brainsway, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.